Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News Feature
  • Published:

Busting the billion-dollar myth: how to slash the cost of drug development

A non-profit organization is proving that new drugs don't have to cost a fortune. Can its model work more broadly?

This is a preview of subscription content, access via your institution

Access options

Buy this article

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

Author information

Authors and Affiliations

Authors

Additional information

Tweet Facebook LinkedIn Weibo Wechat

Related links

Related links

Related links in Nature Research

How to beat the next Ebola 2015-Aug-05

How to beat HIV 2015-Jul-07

Projects set to tackle neglected diseases 2014-Jan-07

Neglected diseases fund touted 2010-May-18

Drug patent plan gets mixed reviews 2009-Feb-23

Related external links

The DNDi

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Maxmen, A. Busting the billion-dollar myth: how to slash the cost of drug development. Nature 536, 388–390 (2016). https://doi.org/10.1038/536388a

Download citation

  • Published:

  • Issue date:

  • DOI: https://doi.org/10.1038/536388a

Search

Quick links

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research